UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
The
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) December 16, 2008
MEDIFAST,
INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
000-23016
|
|
13-3714405
|
(State
or other jurisdiction
|
|
(Commission
File Number)
|
|
(IRS
Employer
|
of
incorporation or organization)
|
|
Ident.
No.)
|
|
|
|
|
|
|
|
11445
Cronhill Drive, Owing Mills, Maryland |
|
21117
|
(Address
of principal executive offices) |
|
(Zip
Code)
|
Registrant's
telephone number, including area code (410)-581-8042
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
Item
7.01
|
Regulation
FD Disclosure
|
The
following information is furnished under “Item 7.01. Regulation FD Disclosure”
and “Item 2.02. Disclosure of Results of Operations and Financial
Condition.”
On December 16, 2008 Medifast, Inc.
(“Medifast”) issued a press release updating Medifast’s full-year 2008 revenue
guidance. A copy of Medifast’s press release is attached
hereto as Exhibit 99.1 and hereby incorporated by reference.
Exhibits
pursuant to Item 7.01
99.1 Press
release dated December 16, 2008, updating 2008 revenue guidance
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
|
MEDIFAST,
INC. |
|
|
|
|
|
|
|
|
|
|
|
Date:
December 17, 2008
|
By:
|
/s/ Michael
S. McDevitt |
|
|
|
Michael
S. McDevitt |
|
|
|
Chief
Executive Officer |
|